Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1995
12/20/1995EP0687461A1 Make-up or skin care composition comprising an aqueous polymer dispersion
12/20/1995EP0687459A1 Hair composition comprising an aqueous polymer dispersion
12/20/1995EP0687301A1 Prohormone convertase transformed cells and polypeptide synthesis
12/20/1995EP0687173A1 Synthetic particulate vectors and method for preparing same
12/20/1995EP0687172A1 Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
12/20/1995EP0645997B1 Cosmetic containing phospholipids and fluorocarbon compounds
12/20/1995EP0600004A4 Sustained-release martrices for dental application.
12/20/1995EP0596049A4 Defoaming composition
12/20/1995EP0576585B1 Viscous surface active composition
12/20/1995EP0554435B1 Process for obtaining a phenylalanine-free dietary product in pill or tablet form
12/20/1995EP0553169B1 A method for drug formulation and a pharmaceutical composition
12/20/1995EP0525063B1 Use of specific fatty acids in the manufacture of a medicament for their Iontophoresis delivery
12/20/1995EP0514523B1 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated
12/20/1995EP0497782B1 Stable, fluid, aqueous pigment dispersions
12/20/1995EP0494996B1 Erodible macroporous hydrogel particles and preparation thereof
12/20/1995EP0462269B1 Cell encapsulating method and apparatus
12/20/1995EP0180581B2 Drug preparations of reduced toxicity
12/20/1995CN1113437A A process for preparing a pharmaceutical composition containing benzothiazole compounds
12/20/1995CN1113434A Drug
12/20/1995CN1113433A Antiparasitic medicine
12/19/1995US5476974 Cleaning compounds, drying
12/19/1995US5476852 Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin
12/19/1995US5476843 Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic
12/19/1995US5476668 Base for film-coating pharmaceuticals and method for preparing same
12/19/1995US5476667 Method for drug formulation and a pharmaceutical composition
12/19/1995US5476665 Azlactone functional particles incorporated in a membrane formed by solvent phase inversion
12/19/1995US5476664 Applying anthralin active ingredient in pharmaceutical carrier; covering with adhesive tape for a predetermined amount of time; repeating; kits
12/19/1995US5476663 Particles containing water soluble drug dispersed in spherical microcapsule matrix composed of copolymer of lactic acid and glycolic acid, excipient; for injection
12/19/1995US5476660 Deposition of materials to surfaces using zwitterionic carrier particles
12/19/1995US5476654 Preparing tablets by mixing terfenadine with a cross-linked sodium carboxymethyl cellulose and a hydrophilic polymer which gels with water
12/19/1995US5476648 Oil in water emulsions
12/19/1995US5476511 Subconjunctival implants for ocular drug delivery
12/19/1995US5475984 Method and apparatus for producing frozen particles using an entrapment zone of atomized cryogenic liquid droplets
12/19/1995CA1337750C Supercritical fluid reverse micelle separation
12/18/1995CA2150741A1 Pediatric lipid emulsion
12/14/1995WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy
12/14/1995WO1995033830A1 Bmp-9 compositions
12/14/1995WO1995033773A1 Lysozyme-degradable biomaterials
12/14/1995WO1995033554A1 Use of a polymer material based on modified hydrocolloids as encapsulating material
12/14/1995WO1995033553A1 Polymeric microbeads and method of preparation
12/14/1995WO1995033511A1 Method and device for long-term delivery of drugs
12/14/1995WO1995033489A1 Stable gel formulation for topical treatment of skin conditions
12/14/1995WO1995033488A1 Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby
12/14/1995WO1995033487A1 Injectable formulations containing a desiccant
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033469A1 Solid antacid and process for producing the same
12/14/1995WO1995033467A2 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
12/14/1995WO1995033466A1 Pyridylbisphosphonates for use as a therapeutical agent
12/14/1995WO1995033465A1 Pharmaceutical composition for treating peripheral circulation disorder
12/14/1995WO1995033459A1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection
12/14/1995WO1995033452A1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use
12/14/1995WO1995033451A1 Non-sedating allergy sinus medication
12/14/1995WO1995033450A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof
12/14/1995WO1995033449A1 Active substance carrier for the controlled release of active substances in the gastro-intestinal tract with delayed passage through the pylorus
12/14/1995WO1995033448A1 Stabilisation of photosensitive materials
12/14/1995WO1995033447A1 Stable reverse and multiple fluorocarbon emulsions
12/14/1995WO1995033446A1 Fast dissolving dosage forms
12/14/1995WO1995033445A1 Implantable device
12/14/1995WO1995033444A1 Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
12/14/1995WO1995033442A1 Use of polymers as film-forming barrier materials
12/14/1995WO1995033433A1 Method for the preparation of pearls and pearls obtained containing an active ingredient with an undefined melting point
12/14/1995DE4420516A1 Polyolpolyhydroxystearate Polyolpolyhydroxystearates
12/14/1995DE4419824A1 Volumen-expandierbares, als Wirkstoffträger insbesondere zur oralen Anwendung geeignete flächige Anwendungsform Volume expandable as drug carriers particularly suitable for oral application area application form
12/14/1995DE4419818A1 Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage Active substance carrier for the controlled release of active ingredients in the gastrointestinal tract with delayed pyloric passage
12/14/1995CA2192314A1 Use of polymers as film-forming barrier materials
12/14/1995CA2192200A1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use
12/14/1995CA2191960A1 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
12/14/1995CA2191863A1 Stabilisation of photosensitive materials
12/14/1995CA2191753A1 Lysozyme-degradable biomaterials
12/14/1995CA2191601A1 Pharmaceutical composition for treating peripheral circulation disorder
12/14/1995CA2191562A1 Fast dissolving dosage forms
12/14/1995CA2191436A1 Stable reverse and multiple fluorocarbon emulsions
12/14/1995CA2191066A1 Solid antacid and process for producing the same
12/14/1995CA2190731A1 Polymeric microbeads and method of preparation
12/14/1995CA2190395A1 Method for the preparation of pearls and pearls obtained containing an active ingredient with an undefined melting point
12/14/1995CA2190181A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof
12/13/1995EP0686399A1 Powdery pharmaceutical preparation and method of manufacturing same
12/13/1995EP0686398A1 Animal bait
12/13/1995EP0686392A1 Thermal granulating process
12/13/1995EP0686391A1 Surfactant-free water-in-oil emulsion
12/13/1995EP0686386A1 Cosmetic and dermatologic composition comprising a stable aqueous dispersion of phytantriol-based gel particles containing a long-chain surfactant as dispersant and stabilizer
12/13/1995EP0686045A1 Excipient stabilization of polypeptides treated with organic solvents
12/13/1995EP0686037A1 Hormone replacement therapy
12/13/1995EP0686034A1 Bisacodyl dosage form
12/13/1995EP0686032A1 Use of 2-chloro-1- 4- (2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans
12/13/1995EP0686031A1 Dye compositions and methods for film coating tablets and the like
12/13/1995EP0686030A1 Immunological response potentiation process
12/13/1995EP0686024A1 Thickening mixture based on guar gum or non-ionic cellulose and a cross-linked polymer, and cosmetic or dermatological hair- or skin-care composition containing said mixture
12/13/1995EP0573473B1 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
12/13/1995EP0526524B1 Pharmaceutical compositions
12/13/1995EP0521988B1 Device for iontophoretic drug delivery
12/13/1995EP0484543B1 Plaster
12/13/1995CN1113243A 8-amino-10-(azabicycloalkyl)-pyrido(1,2,3,-D,E)(1,3,4) benzoxadiazine derivatives
12/13/1995CN1113157A Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation
12/13/1995CN1113156A Liquid hypotensor with cephalocatharic function
12/13/1995CN1113155A Production method for "Dieda Wanhuayou"- a drug for treating traumatic injury
12/13/1995CN1113154A Rehabilitation pill for brains and its production technology
12/13/1995CN1113143A Cosmelic and/or dematological comporihori with a hydoplilic canvei and viramnic which can be mixed immedicarely before us
12/13/1995CN1113142A Compositions based on-pyrones for inducing and stimulating hair growth and/or retarding hair loss, and use
12/12/1995US5475023 Aqueous pharmaceutical formulations of sodium cromoglycate
1 ... 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2736 ... 2991